Profile Details

Contact

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Melisa S.

United States

Clinical Researcher and Scientist

Profile Summary

Experienced researcher with scientific knowledge and expertise in several therapeutic areas, including: metabolic disorders, ophthalmology, gene therapy, oncology, stem cell transplantation, rare diseases, gastroenterology, infectious diseases; hands on experience writing manuscripts, reports, book chapters; fluent in Spanish (native language) and Italian (intermediate in writing and spoken). Also, background in pharmacovigilance, clinical research coordination, regulatory affairs and patient healthcare.

Subject Matter Expertise

• ★ Clinical Trials
• ★ Pharmacovigilance/Drug Safety Monitoring
• ☆ Virology
• ☆ Retrovirology
• ☆ Immunoassay
• ☆ Molecular Biology
• ☆ Genetics
• ☆ Stem Cell Research
• ☆ Basic Immunology
• ☆ Biotechnology & Bioengineering
• ☆ Database Management
• ☆ Data Analysis
• ☆ Data Management
• ☆ Spanish
• ☆ Italian
• ☆ Ophthalmology
• ☆ Pediatric Medicine
• ☆ Oncology
• ☆ Gastroenterology & Hepatology
• ☆ Diabetes
• ☆ Hematology
• ☆ Infectious Disease
• ☆ Organ Transplant
• ☆ Rare Diseases
• ☆ Home Health Care
• ☆ Regulatory Affairs
• ☆ Gene Therapy
• ☆ Manuscript & Journal Article Writing

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Work Experience

Safety Reporting Administrator

Pharmaceutical Product Development Inc

July 2017 - Present

Freelance translator Spanish-English

Cactus Communications Inc

March 2017 - Present

Clinical Research Associate

Pharmaceutical Product Development Inc

July 2019 - July 2021

Freelance editor

Enago

March 2017 - July 2017

Clinical Research Fellow

University of North Carolina at Chapel Hill

October 2016 - June 2017

Clinical Research Fellow

University of North Carolina Hospitals

August 2016 - October 2016

Regulatory Affairs Intern

Chiesi Pharmaceuticals Inc

August 2016 - October 2016

Post-doctoral Research Associate Fellow

North Carolina State University

August 2014 - July 2016

Post-doctoral Research Fellow

Wake Forest School of Medicine

February 2011 - July 2014

Graduate Research Assistant

University of Nevada Reno

February 2006 - December 2010

Education

Medical Product Safety and Pharmacovigilance Certificate

Durham Technical Community College

2017 - Present

Data Management Certificate

Durham Technical Community College

2017 - Present

Ph.D in Cellular and Molecular Biology

University of Nevada Reno

January 2006 - December 2010

Licenciatura en Biotecnologia (Equivalent to a Master In Biotechnology)

Universidad Nacional de Rosario Facultad de Ciencias Bioquimicas y Farmaceuticas

March 1996 - April 2005

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., Vance, M., Llanga, T., Bennett, W., Woodard, K., Murlidharan, G., et al.(2016). AAV Gene Therapy for MPS1-associated Corneal Blindness . Scientific Reports. 6.

(2014). Evaluation of gene delivery strategies to efficiently over-express functional hla-G on human bone marrow stromal cells. Molecular Therapy.

(2014). Perivascular stromal cells as a potential reservoir of human cytomegalovirus . American Journal of Transplantation. 14. (4). p. 820-830.

Soland, M.A., Bego, M., Colletti, E., Zanjani, E.D., St. Jeor, S., Porada, C.D., Almeida-Porada, G.(2013). Mesenchymal Stem Cells Engineered to Inhibit Complement-Mediated Damage . PLoS ONE. 8. (3).

Almeida-Porada, G., Soland, M., Boura, J., Porada, C.D.(2013). Regenerative medicine: Prospects for the treatment of inflammatory bowel disease . Regenerative Medicine. 8. (5). p. 631-644.

(2013). Mesenchymal stem cells contribute to endogenous FVIII: C production . Journal of Cellular Physiology. 228. (5). p. 1010-1016.

(2013). EphB2 isolates a human marrow stromal cell subpopulation with enhanced ability to contribute to the resident intestinal cellular pool . FASEB Journal. 27. (6). p. 2111-2121.

(2012). HCMV Protein LUNA Is Required for Viral Reactivation from Latently Infected Primary CD14⁺Cells . PLoS ONE. 7. (12).

(2012). Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation . Journal of General Virology. 93. (4). p. 722-732.

(2012). Modulation of human mesenchymal stem cell immunogenicity through forced expression of human cytomegalovirus US proteins . PLoS ONE. 7. (5).

Soland, M.(2011). Modulation of mesenchymal stem cell immunogenicity through stable expression of human cytomegalovirus proteins . Rejuvenation Research. 14. (3). p. 342-343.

BOOK CHAPTER

(2015). AAV Biology, Infectivity and Therapeutic Use from Bench to Clinic . Gene Therapy Principles and Challenges.